cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2025-40-1-166-176cardiotomsk-2645Research ArticleКЛИНИЧЕСКИЕ СЛУЧАИCLINICAL CASESКлинический случай тяжелой недостаточности аортального клапана вследствие анкилозирующего спондилитаClinical case of severe aortic valve insufficiency due to ankylosing spondyloarthritishttps://orcid.org/0000-0002-3294-6568РеброваН. В.RebrovaN. V.

Реброва Наталья Васильевна, канд. мед. наук, заведующий отделением атеросклероза и хронической ишемической болезни сердца

634012, Томск, ул. Киевская, 111а

Natalya V. Rebrova, Cand. Sci. (Med.), Head of the Department of Atherosclerosis and Coronary Artery Disease

111a, Kievskaya str., Tomsk, 634012

rebrova2009@mail.ruhttps://orcid.org/0000-0001-6850-182XКрапивинаА. С.KrapivinaA. S.

Крапивина Анастасия Сергеевна, лаборант-исследователь, отделение атеросклероза и хронической ишемической болезни сердца

634012, Томск, ул. Киевская, 111а

Anastasia S. Krapivina, Laboratory Research Assistant, Department of Atherosclerosis and Coronary Artery Disease

111a, Kievskaya str., Tomsk, 634012

ya.anastasiya.krapivina99@yandex.ruhttps://orcid.org/0000-0001-7161-4622СвязоваН. Н.SviazovaN. N.

Связова Наталья Николаевна, канд. мед. наук, врач ультразвуковой диагностики, младший научный сотрудник, отделение атеросклероза и хронической ишемической болезни сердца

634012, Томск, ул. Киевская, 111а

Natalia N. Sviazova, Cand. Sci. (Med.), Ultrasound Diagnostics Doctor, Junior Research Scientist, Department of Atherosclerosis and Coronary Artery Disease

111a, Kievskaya str., Tomsk, 634012

gladkihn@cardio-tomsk.ruЩербаньН. В.ShcherbanN. V.

Щербань Наталья Викторовна, врач-рентгенолог, кабинет рентгеновской компьютерной томографии, отделение рентгеновских и томографических методов диагностики

634012, Томск, ул. Киевская, 111а

Natalya V. Shcherban, Radiologist of X-ray Computed Tomography Room, Department of Radiology and Tomography

111a, Kievskaya str., Tomsk, 634012

rgnatvik@gmail.comhttps://orcid.org/0000-0002-8543-6027СтепановИ. В.StepanovI. V.

Степанов Иван Вадимович, канд. мед. наук, заведующий патологоанатомическим отделением

634012, Томск, ул. Киевская, 111а

Ivan V. Stepanov, Cand. Sci. (Med.), Head of the Pathoanatomical Department

111a, Kievskaya str., Tomsk, 634012

i_v_stepanov@mail.ruhttps://orcid.org/0000-0002-2103-2437ЛихомановК. С.LikhomanovK. S.

Лихоманов Константин Сергеевич, канд. мед. наук, врач-кардиолог, отделение атеросклероза и хронической ишемической болезни сердца

634012, Томск, ул. Киевская, 111а

Konstantin S. Likhomanov, Cand. Sci. (Med.), Cardiologist, Department of Atherosclerosis and Chronic Coronary Heart Disease

111a, Kievskaya str., Tomsk, 634012

lks@cardio-tomsk.ruНаучно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук (НИИ кардиологии Томского НИМЦ)РоссияCardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russia (Cardiology Research Institute, Tomsk NRMC)Russian Federation202513042025401166176Copyright © Реброва Н.В., Крапивина А.С., Связова Н.Н., Щербань Н.В., Степанов И.В., Лихоманов К.С., 20252025Реброва Н.В., Крапивина А.С., Связова Н.Н., Щербань Н.В., Степанов И.В., Лихоманов К.С.Rebrova N.V., Krapivina A.S., Sviazova N.N., Shcherban N.V., Stepanov I.V., Likhomanov K.S.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/2645

Аортит и недостаточность аортального клапана относятся к внескелетным проявлениям анкилозирующего спондилита (АС). Торпидное течение заболеваний является причиной позднего обращения за медицинской помощью на стадии необратимых изменений и выраженного нарушения функции сердечно-сосудистой и костно-мышечной систем. В статье представлен клинический случай успешного хирургического лечения тяжелой аортальной недостаточности у пациента с поздно диагностированным АС. Обсуждаются вопросы кардиоваскулярной патологии при АС, междисциплинарного взаимодействия врачей, выбора противоревматической терапии и периоперационного ведения пациента с АС с очень высоким сердечно-сосудистым риском.

Aortitis and aortic valve insufficiency are referred to as extraskeletal manifestations of ankylosing spondylitis (AS). Torpid course of diseases is the reason for late seeking medical care at the stage of irreversible changes and severe dysfunction of the cardiovascular and musculoskeletal systems. The article presents a clinical case of successful surgical treatment of severe aortic valve insufficiency in a patient with late diagnosed AS. The problems of cardiovascular pathology in AS, interdisciplinary interaction of doctors, choice of antirheumatic therapy and perioperative management of a very high cardiovascular risk patient with AS are discussed.

анкилозирующий спондилитнедостаточность аортального клапанааортитсердечно-сосудистый рискankylosing spondylitisaortic valve insufficiencyaortitiscardiovascular riskReferencesWard M.M. Lifetime risks of valvular heart disease and pacemaker use in patients with ankylosing spondylitis. J. Am. Heart Assoc. 2018;7:e010016. https://doi.org/10.1161/jaha.118.010016Ward M.M. Lifetime risks of valvular heart disease and pacemaker use in patients with ankylosing spondylitis. J. Am. Heart Assoc. 2018;7:e010016. https://doi.org/10.1161/jaha.118.010016Bhattad P.B., Kulkarni M., Patel P.D., Roumia M. Cardiovascular morbidity in ankylosing spondylitis: a focus on inflammatory cardiac disease. Cureus. 2022;14(6):e25633. https://doi.org/10.7759/cureus.25633Bhattad P.B., Kulkarni M., Patel P.D., Roumia M. Cardiovascular morbidity in ankylosing spondylitis: a focus on inflammatory cardiac disease. Cureus. 2022;14(6):e25633. https://doi.org/10.7759/cureus.25633Navarini L., Currado D., Marino A., Di Donato S., Biaggi A., Caso F. et al. Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis. Sci. Rep. 2022;7(12):7498. https://doi.org/10.1038/s41598-022-11640-8Navarini L., Currado D., Marino A., Di Donato S., Biaggi A., Caso F. et al. Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis. Sci. Rep. 2022;7(12):7498. https://doi.org/10.1038/s41598-022-11640-8Lai Y., Zhang Y., Mo S. Ma J., Ni T., Lei Z. et al. Prevalence of comorbidities and risk factors in spondyloarthritis: results of a cross-sectional study. Ann. Rheum. Dis. 2022;81:e43. https://doi.org/10.1136/annrheumdis-2020-217313Lai Y., Zhang Y., Mo S. Ma J., Ni T., Lei Z. et al. Prevalence of comorbidities and risk factors in spondyloarthritis: results of a cross-sectional study. Ann. Rheum. Dis. 2022;81:e43. https://doi.org/10.1136/annrheumdis-2020-217313Chetrit M., Khan M.A., Kapadia S. State of the art management of aortic valve disease in ankylosing spondylitis. Curr. Rheumatol. Rep. 2020;22(6):23. https://doi.org/10.1007/s11926-020-00898-4Chetrit M., Khan M.A., Kapadia S. State of the art management of aortic valve disease in ankylosing spondylitis. Curr. Rheumatol. Rep. 2020;22(6):23. https://doi.org/10.1007/s11926-020-00898-4Zhao S.S., Pittam B., Harrison N.L., Ahmed A.E., Goodson N.J., Hughes D.M. Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(4):1620– 1628. https://doi.org/10.1093/rheumatology/keaa807Zhao S.S., Pittam B., Harrison N.L., Ahmed A.E., Goodson N.J., Hughes D.M. Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(4):1620– 1628. https://doi.org/10.1093/rheumatology/keaa807Buleu F., Sirbu E., Caraba A., Dragan S. Heart involvement in inflammatory rheumatic diseases: a systematic literature review. Medicina (Kaunas). 2019;55(6):249. https://doi.org/10.3390/medicina55060249Buleu F., Sirbu E., Caraba A., Dragan S. Heart involvement in inflammatory rheumatic diseases: a systematic literature review. Medicina (Kaunas). 2019;55(6):249. https://doi.org/10.3390/medicina55060249Bolaji O., Oriaifo O., Adabale O., Dilibe A., Kuruvada K., Ouedraogo F. et al. A meta-analysis of left ventricular dysfunction in ankylosing spondylitis. J. Clin. Hypertens. (Greenwich). 2024;26(7):772–788. https://doi.org/10.3390/medicina55060249Bolaji O., Oriaifo O., Adabale O., Dilibe A., Kuruvada K., Ouedraogo F. et al. A meta-analysis of left ventricular dysfunction in ankylosing spondylitis. J. Clin. Hypertens. (Greenwich). 2024;26(7):772–788. https://doi.org/10.3390/medicina55060249Zhang M., Zhang H., Dai D., Shen B., Ruan D. Risk factors and clinical significance of ankylosing spondylitis combined with early-onset coronary heart disease. Altern. Ther. Health Med. 2024:AT10104. Online ahead of print.Zhang M., Zhang H., Dai D., Shen B., Ruan D. Risk factors and clinical significance of ankylosing spondylitis combined with early-onset coronary heart disease. Altern. Ther. Health Med. 2024:AT10104. Online ahead of print.Годзенко А.А., Корсакова Ю.О., Румянцева О.А., Бочкова А.Г., Бадокин В.В., Эрдес Ш.Ф. Прогрессирование патологии аорты и клапанов сердца у больных анкилозирующим спондилитом. Научно-практическая ревматология. 2017;55(5):509–513. https://doi.org/10.14412/1995-4484-2017-509-513Godzenko A.A., Korsakova Yu.O., Rumyantseva O.A., Bochkova A.G., Badokin V.V., Erdes Sh.F. Progression of aortic and valvular heart diseases in patients with ankylosing spondylitis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(5):509– 513. (In Russ.). https://doi.org/10.14412/1995-4484-2017-509-513Sherlock J.P., Joyce-Shaikh B., Turner S.P., Chao C.C., Sathe M., Grein J. et al. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4–CD8– entheseal resident T cells. Nat. Med. 2012;18(7):1069– 1076. https://doi.org/10.1038/nm.2817Sherlock J.P., Joyce-Shaikh B., Turner S.P., Chao C.C., Sathe M., Grein J. et al. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4–CD8– entheseal resident T cells. Nat. Med. 2012;18(7):1069– 1076. https://doi.org/10.1038/nm.2817Reinhardt A., Yevsa T., Worbs T., Lienenklaus S., Sandrock I., Oberdörfer L. et al. Interleukin-23–dependent γ/δ T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice. Arthritis Rheumatol. 2016;68(10):2476–2486. https://doi.org/10.1002/art.39732Reinhardt A., Yevsa T., Worbs T., Lienenklaus S., Sandrock I., Oberdörfer L. et al. Interleukin-23–dependent γ/δ T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice. Arthritis Rheumatol. 2016;68(10):2476–2486. https://doi.org/10.1002/art.39732Balčiūnaitė A., Budrikis A., Rumbinaitė E., Sabaliauskienė J., Patamsytė V., Lesauskaitė V. Ankylosing spondyloarthritis resulting severe aortic insufficiency and aortitis: exacerbation of ankylosing spondyloarthritis and stenosis of the main left coronary artery after mechanical aortic valve implantation with cardiopulmonary bypass. Case Rep. Rheumatol. 2020;2020:9538527. https://doi.org/10.1155/2020/9538527Balčiūnaitė A., Budrikis A., Rumbinaitė E., Sabaliauskienė J., Patamsytė V., Lesauskaitė V. Ankylosing spondyloarthritis resulting severe aortic insufficiency and aortitis: exacerbation of ankylosing spondyloarthritis and stenosis of the main left coronary artery after mechanical aortic valve implantation with cardiopulmonary bypass. Case Rep. Rheumatol. 2020;2020:9538527. https://doi.org/10.1155/2020/9538527Huffer L.L., Furgerson J.L. Aortic root dilatation with sinus of Valsalva and coronary artery aneurysms associated with ankylosing spondylitis. Tex. Heart Inst. J. 2006;33(1):70–73.Huffer L.L., Furgerson J.L. Aortic root dilatation with sinus of Valsalva and coronary artery aneurysms associated with ankylosing spondylitis. Tex. Heart Inst. J. 2006;33(1):70–73.Bengtsson K., Klingberg E., Deminger A., Wallberg H., Jacobsson L.T.H., Bergfeldt L. et al. Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study. RMD Open. 2019;5(2):e001053. https://doi.org/10.1136/rmdopen-2019-001053Bengtsson K., Klingberg E., Deminger A., Wallberg H., Jacobsson L.T.H., Bergfeldt L. et al. Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study. RMD Open. 2019;5(2):e001053. https://doi.org/10.1136/rmdopen-2019-001053Fakih O., Desmarets M., Martin B., Prati C., Wendling D., Monnet E. et al. Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study. Rheumatology (Oxford). 2023;62(10):3317–3322. https://doi.org/10.1093/rheumatology/kead072Fakih O., Desmarets M., Martin B., Prati C., Wendling D., Monnet E. et al. Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study. Rheumatology (Oxford). 2023;62(10):3317–3322. https://doi.org/10.1093/rheumatology/kead072Kim J.W., Yoon J.S., Park S., Kim H., Lee J.S., Choe J.Y. Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis. Ann. Rheum. Dis. 2024;83(8):1028–1033. https://doi.org/10.1136/ard-2023-225406Kim J.W., Yoon J.S., Park S., Kim H., Lee J.S., Choe J.Y. Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis. Ann. Rheum. Dis. 2024;83(8):1028–1033. https://doi.org/10.1136/ard-2023-225406Liew J.W., Treu T., Park Y., Ferguson J.M., Rosser M.A., Ho Y.L. et al. The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis. Semin. Arthritis Rheum. 2024;68:152482. https://doi.org/10.1016/j.semarthrit.2024.152482Liew J.W., Treu T., Park Y., Ferguson J.M., Rosser M.A., Ho Y.L. et al. The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis. Semin. Arthritis Rheum. 2024;68:152482. https://doi.org/10.1016/j.semarthrit.2024.152482Genovese M.C., Mysler E., Tomita T., Papp K.A., Salvarani C., Schwartzman S. et al. Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials. Rheumatology. 2020;59:3834–3844. https://doi.org/10.1093/rheumatology/keaa189Genovese M.C., Mysler E., Tomita T., Papp K.A., Salvarani C., Schwartzman S. et al. Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials. Rheumatology. 2020;59:3834–3844. https://doi.org/10.1093/rheumatology/keaa189

The authors declare that there are no conflicts of interest present.